Pulling SEC filings + quote and writing the call…

Glimpse Group, Inc.
Last earnings -3.1% on 2026-05-14
Cheap, cash-rich immersive-tech microcap trading near book with losses shrinking fast — improving, but still unprofitable and lumpy.
Revenue $10.5M · FY2025
Glimpse is a $17.4M immersive-tech (VR/AR/spatial computing) microcap whose story is a genuine, measurable turnaround rather than the usual sub-$1 value trap. FY2025 revenue grew 19.6% to $10.5M at a healthy 67.6% gross margin, and the loss lines all improved sharply: net loss narrowed 60.1% to -$2.55M, operating loss 58.6% to -$2.74M, and operating cash flow reached near-breakeven at -$274K (up 94.7%). The balance sheet is the strongest part of the case — cash jumped 269.7% to $6.83M (≈40% of the entire market cap), total liabilities fell 41.7% to $2.34M for a pristine 0.14x liabilities/equity, and the stock trades essentially at book value ($16.9M equity ÷ 21.1M shares ≈ $0.80 vs. $0.82 price). At 1.6x sales for a ~20% grower with two-thirds gross margins, you are not overpaying.
But the quality bar is not met, and the filing is candid about why. Management describes itself as an 'early stage technology company' with a $65.6M accumulated deficit that has never turned a profit, and explicitly warns it 'may continue to generate negative cash flow' that 'may eventually require us to raise capital' — with equity financings carrying 'a dilutive effect.' Dilution is already happening: share count rose 16% YoY. Revenue is lumpy and acquisition-driven, not durable compounding — it swung from $13.5M (FY2023) down to $8.8M (FY2024) and back to $10.5M (FY2025), so the 19.6% 'growth' is partly recovery, not a clean trend. The MD&A pins the future on one product (Spatial Core, via Brightline Interactive) in a market the company itself calls 'increasingly competitive' against rivals with 'substantially greater financial and other resources.'
Is GGRP a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.42M | $7.27M | $13.5M | $8.80M | $10.5M |
| Gross profit | $1.96M | $6.03M | $9.22M | $5.86M | $7.12M |
| Operating income | -$5.95M | -$6.34M | -$28.8M | -$6.62M | -$2.74M |
| Net income | -$6.09M | -$5.97M | -$28.6M | -$6.39M | -$2.55M |
| Diluted EPS | — | -$0.51 | -$2.05 | -$0.38 | -$0.13 |
| Net margin | -178.0% | -82.1% | -211.9% | -72.6% | -24.2% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Board/management change disclosed with press release; leadership transition underway
Officer or director change reported (Item 5.02); no financial impact disclosed
Entered material definitive agreement plus other-event disclosure — potential new deal
Q3 FY26 10-Q: revenue up, losses shrinking, ~$6.8M cash funds ~12mo of ops
Q3 FY26 10-Q: revenue up, losses shrinking, ~$6.8M cash funds ~12mo of ops
Nasdaq continued-listing deficiency notice received — delisting risk if not cured
Q2 FY26 10-Q: improving margins, cash cushion maintained
Q2 FY26 10-Q: improving margins, cash cushion maintained
Filed S-3 shelf — enables future equity/debt raises and possible dilution
Sources: SEC EDGAR (CIK 0001854445, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 7/4/2026, 5:02:30 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 1:02 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-05-18 | Gates Tyler President and CEO | Award | 36.4K @ $0.55 | $20.0K |
| 2025-12-18 | Bentovim Lyron L President and CEO | Award | 3.17K @ $0.98 | $3.11K |
| 2024-12-11 | Bentovim Lyron L President and CEO | Award | 10.6K @ $1.15 | $12.2K |
| 2024-05-24 | Bentovim Lyron L President and CEO | Award | 1.78K @ $1.07 | $1.90K |
| 2023-04-03 | Bentovim Lyron L President and CEO | Award | 7.10K @ $4.10 | $29.1K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median